"JNJ-38877605CNNCI" . "An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antineoplastic activity. c-Met inhibitor JNJ-38877605 selectively inhibits c-Met, a receptor tyrosine kinase (RTK) involved in cancer cell survival and invasiveness, and tumor angiogenesis. c-Met is also known as hepatocyte growth factor receptor (HGFR).NCI" . . "CL383572"^^ . . "c-Met_Inhibitor_JNJ-38877605"^^ . "c-Met Inhibitor JNJ-38877605"^^ . "c-Met Inhibitor JNJ-38877605"^^ . "Organic Chemical"^^ . "594157"^^ . "Pharmacologic Substance"^^ . "C77893"^^ . "c-Met Inhibitor JNJ-38877605PTNCI" . "594157"^^ .